Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC Therapy

Study Overview
=================
Brief Summary
-----------------
Single sequence clinical study designed to evaluate the effectiveness of B. Braun PA on improved clinical outcomes, indwell time and first stick success of PIVC using B. Braun Peripheral Advantage (PA) by Registered Nurses (RNs). The study will be conducted in the Emergency Department (ED) and/or Medical Surgical (MS) floor(s)/unit(s) in multiple hospitals.

Official Title
-----------------
Assessment of the Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC Therapy

Conditions
-----------------
Complications Associated With Device

Intervention / Treatment
-----------------
* Device: B. Braun Peripheral Advantage (PA) Program
* Device: Hospital Standard of Care


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: RNs must complete all of the required B. Braun trainings in Stage 2 in order to participate in Stages 3 and 4. Subjects must meet all of the following Inclusion Criteria: Male or female aged ≥18 years; The subject or the subject's LAR voluntarily agrees that the subject will participate in this study and is able to understand and sign the Informed Consent Form (ICF); Have a medical condition that requires a PIVC anticipated to last for at least 48 hours; Have intact skin at the site of insertion; If the patient has an existing IV in one arm he/she must have a viable contralateral arm for additional PIVC insertion. Exclusion Criteria: Subjects must not meet any of the following Exclusion Criteria: Are currently participating in another medical device or pharmaceutical study; In the opinion of the Investigator, would not be suitable candidates for this study; The subject or his/her LAR is an employee of the Investigator or study center, or the sponsor, or have direct involvement in the study or other studies under the direction of that Investigator or study center, or are a family member of the employees or the Investigator; Have a laboratory confirmed bloodstream infection within 48 hours prior to participation in the study. The assessment is based on clinical observations and not routine for all subjects; Patient has an existing non study related IV; Was removed from any Stage of the study due to an AE associated with the PIVC.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Non-Randomized
Intervention Model: Sequential Assignment
Interventional Model Description: The study will be divided into 4 Stages: 3 Clinical Stages and 1 Educational Stage.
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Stage 1 Baseline<br>Study site to use standard of care PIVC device(s) and procedure(s) on patients. | Device: Hospital Standard of Care<br>* Standard of Care for PIVC access per hospital protocol<br>|
| Other: Stage 2 Education<br>RN education and training in the use of B. Braun PIVC products, devices and procedures. | Device: B. Braun Peripheral Advantage (PA) Program<br>* B. Braun PA includes: Christie VeinViewer® Vision2 , Introcan Safety® IV Catheters, STEADYCare™ Smallbore Extension Set, and the PA Education<br>|
| Other: Stage 3 Run-In<br>Familiarization of study RNs with the B. Braun devices and procedures in a clinical setting. | Device: B. Braun Peripheral Advantage (PA) Program<br>* B. Braun PA includes: Christie VeinViewer® Vision2 , Introcan Safety® IV Catheters, STEADYCare™ Smallbore Extension Set, and the PA Education<br>|
| Other: Stage 4 Post-Education<br>Study site uses B. Braun PIVC device(s) and procedure(s) on patients. | Device: B. Braun Peripheral Advantage (PA) Program<br>* B. Braun PA includes: Christie VeinViewer® Vision2 , Introcan Safety® IV Catheters, STEADYCare™ Smallbore Extension Set, and the PA Education<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Complications Associated With PIVC Use | [Planned] Outcome: Evaluate the impact of B. Braun Peripheral Advantage (PA) Program on the number of stick attempts with complications associated with PIVC use. Due to the early termination in Stage 1, no data were collected from Stages 2 through 4 to perform comparative analyses. | Through study completion, an estimate of 1 year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Catheter Indwell Time | Evaluate the effect of B. Braun PA on catheter indwell time associated with catheter insertion. | Up to 48 hours and between 48 and 168 hours | 
| First Attempt Success Rates (First Stick Success) | Evaluate the effect of B. Braun PA on first attempt success rates (first stick success) associated with catheter insertion. | Initial needle stick (baseline) | 
| Aggregate Costs Associated With Catheter Insertion | Evaluate the effect of B. Braun PA on aggregate costs associated with catheter insertion. | Through study completion, an estimate of 1 year |